New York State Common Retirement Fund
AXSM icon

New York State Common Retirement Fund’s Axsome Therapeutics AXSM Stock Holding History

New York State Common Retirement Fund’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
61,024
+10,911
+22% +$2.37M 0.02% 593
2026
Q1 		$8.47M Buy
50,113
+7,604
+18% +$1.31M 0.01% 798
2025
Q4 		$7.76M Buy
42,509
+9,235
+28% +$1.29M 0.01% 849
2025
Q3 		$4.04M Buy
33,274
+875
+3% +$98.6K 0.01% 1158
2025
Q2 		$3.38M Sell
32,399
-1,182
-4% -$125K ﹤0.01% 1223
2025
Q1 		$3.92M Buy
33,581
+11,090
+49% +$1.26M 0.01% 1151
2024
Q4 		$1.9M Buy
22,491
+8,843
+65% +$813K ﹤0.01% 1440
2024
Q3 		$1.23M Sell
13,648
-4,400
-24% -$384K ﹤0.01% 1587
2024
Q2 		$1.45M Sell
18,048
-6,482
-26% -$480K ﹤0.01% 1595
2024
Q1 		$1.96M Sell
24,530
-3,517
-13% -$295K ﹤0.01% 1482
2023
Q4 		$2.23M Buy
28,047
+3,052
+12% +$204K ﹤0.01% 1422
2023
Q3 		$1.75M Buy
24,995
+1,425
+6% +$107K ﹤0.01% 1500
2023
Q2 		$1.69M Sell
23,570
-1,796
-7% -$132K ﹤0.01% 1556
2023
Q1 		$1.56M Sell
25,366
-5,073
-17% -$333K ﹤0.01% 1656
2022
Q4 		$2.35M Buy
30,439
+8,866
+41% +$530K ﹤0.01% 1556
2022
Q3 		$963K Buy
21,573
+78
+0.4% +$3.9K ﹤0.01% 1992
2022
Q2 		$823K Sell
21,495
-43
-0.2% -$1.36K ﹤0.01% 2126
2022
Q1 		$891K Hold
21,538
– – ﹤0.01% 2168
2021
Q4 		$814K Sell
21,538
-271,017
-93% -$9.97M ﹤0.01% 2187
2021
Q3 		$9.64M Sell
292,555
-5,039
-2% -$196K 0.01% 1012
2021
Q2 		$20.1M Sell
297,594
-6,028
-2% -$362K 0.02% 681
2021
Q1 		$17.2M Buy
303,622
+49,588
+20% +$3.49M 0.02% 710
2020
Q4 		$20.7M Buy
254,034
+47,082
+23% +$3.52M 0.02% 628
2020
Q3 		$14.7M Buy
206,952
+73,921
+56% +$5.76M 0.02% 707
2020
Q2 		$10.9M Buy
133,031
+9,238
+7% +$711K 0.01% 831
2020
Q1 		$7.28M Buy
123,793
+54,845
+80% +$4.47M 0.01% 910
2019
Q4 		$7.13M Buy
68,948
+40,348
+141% +$1.63M 0.01% 1098
2019
Q3 		$579K Buy
28,600
+3,600
+14% +$92.5K ﹤0.01% 2253
2019
Q2 		$644K Buy
+25,000
New +$501K ﹤0.01% 2242
2017
Q2 		– Sell
-8,372
Closed -$33K – 3186
2017
Q1 		$33K Buy
8,372
+1
+0% +$5 ﹤0.01% 3094
2016
Q4 		$57K Hold
8,371
– – ﹤0.01% 3051
2016
Q3 		$66K Hold
8,371
– – ﹤0.01% 3054
2016
Q2 		$63K Buy
+8,371
New +$77.1K ﹤0.01% 3064

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

New York State Common Retirement Fund's AXSM Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Axsome Therapeutics (AXSM) stake by 22% in Q2 2026, buying an estimated $2.37M and bringing the position to 61,024 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #593.

New York State Common Retirement Fund first reported a position in AXSM in Q2 2016 and has held it in 33 quarters since. The position peaked at $20.7M in Q4 2020. 128 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • New York State Common Retirement Fund held 61,024 shares of Axsome Therapeutics worth $14.9M as of Q2 2026.
  • New York State Common Retirement Fund bought 10,911 Axsome Therapeutics shares in Q2 2026, an estimated $2.37M.
  • Axsome Therapeutics made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #593 holding.
  • New York State Common Retirement Fund first reported a position in Axsome Therapeutics in Q2 2016 and has held it in 33 quarters since.
  • New York State Common Retirement Fund's Axsome Therapeutics position peaked at $20.7M in Q4 2020.
  • 128 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.